Neuren Pharmaceuticals Limited

A$23.24As of Sun 8 Nov 2026, 12:00 UTC
ASX:NEUHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 39.06%
Div yield 1.29%
ROE 6.17%
Biotechnology
Beta (5Y) 1.59
PE TTM 149.1
TSR TTM 7.58%
Mkt cap A$2.946B
ROIC 22.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$24
5.12%
(55.47%)
Hold 9|11|1|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.39
0.38
0.40
0.41
23.73%
7.51%
3.21%
1.51%
Revenue$M
133.0
132.4
133.0
131.3
9.02%
5.64%
7.57%
3.24%
Peers (US$2.024B)
Cap (US$)
PE
2.462B
16.13x
838.4M
4.401x
Capital
TTM
5Y
10Y
Leveragex
0.668
(0.047)
(0.047)
EBIT/Intx
0.597
0.181
0.159
Own earn%
(455.18)
130.20
132.70
Sh yield%
49.22
36.67
36.77
Owners
Insiders/Inst%
12.13
46.57
Short interest%
2.49
SBC / revenue%
5.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
23–26
$1 testx
0.5
Incr. ROIC%
82